Form 13-F position report

INDIVIOR PHARMACEUTICALS INC Call options

Reported by EQUITEC PROPRIETARY MARKETS LLC

INDVZZZZ CUSIP 45579U109 Manager CIK 0001143261

First reported at 30,000 underlying shares controlled this quarter.

New
% of reported 13F value 0.27% This manager · Q3 2026
Underlying shares 30,000 Quarter-end amount reported
Reported notional value $1,075,500 Underlying-share value; not option premium
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 1075500

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for INDIVIOR PHARMACEUTICALS INC held by EQUITEC PROPRIETARY MARKETS LLC.
Quarter Activity Underlying shares Change % of reported 13F Reported notional value Filed Source filing
Q3 2026 New 30,000 +30,000 (0.0%) 0.27% $1,075,500 2026-11-04

Who else reported the position

6 managers reported INDIVIOR PHARMACEUTICALS INC for Q3 2026.

Managers reporting INDIVIOR PHARMACEUTICALS INC in Q3 2026.
Manager Activity Underlying shares Change % of reported 13F Reported notional value Tenure
JANE STREET GROUP LLC Reduced 511,400 -845,300 < 0.01% $18,333,690 3 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Reduced 232,700 -674,600 < 0.01% $8,342,295 3 qtrs
Caption Management LLC New 100,000 +100,000 0.01% $3,585,000 3 qtrs
EQUITEC PROPRIETARY MARKETS LLC This report New 30,000 +30,000 0.27% $1,075,500 1 qtr
CITADEL ADVISORS LLC Reduced 24,400 -93,100 < 0.01% $874,740 3 qtrs
UBS Group AG Reduced 18,700 -1,300 < 0.01% $670,395 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 04, 2026
Filing type
13F-HR
Position type
Call options

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.